has anyone died from compounded semaglutide Novo Nordisk tackles harm Ozempic fakes with global authorities Have patients been harmed by

Brief temperature excursions, a few hours at room temperature, are generally considered less concerning than extended exposure

Implications for Treatment Persistence and Outcomes Taken together, discontinuations and interruptions in GLP-1RA use were common in this cohort, particularly during the first year of treatment

Key takeaways Chinas GLP-1 market is booming, driven by rising diabetes and obesity prevalence, expanded indications (e.g., MASH, CKD, Alzheimers), policy support and momentum from global leaders and innovative local players

Individual response varies based on starting weight, body composition, adherence, diet quality, activity level, and genetics